Compass Therapeutics, Inc. CMPX
- CTX-471 — Melanoma Phase 1
- CTX-471 — Small Cell Lung Cancer Phase 1
- CTX-471 — Mesothelioma Phase 1
CD137 (3 companies · 5 programs)
Companies with an active program directed at CD137.
Adagene Inc. ADAG
- ADG206 — Solid Tumors Phase 1
Aptevo Therapeutics Inc. APVO
- ALG.APV-527 — Solid Tumors Phase 1